International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer


Recommended Conferences for Oncogenomics


As per available reports about 57 relevant Journals, 26 Conferences, 705 Workshops are presently dedicated exclusively to Oncogenomics and about 2504 Open Access articles are being published on Oncogenomics.

Oncogenomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. Oncogenomics is synonymous with "cancer genomics". Cancer is a genetic disease caused by accumulation of mutations to DNA leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers, and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin, and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

The completion of the Human Genome Project has greatly facilitated the field of oncogenomics and has increased the abilities of researchers to find cancer causing genes. In addition, the sequencing technologies now available for sequence generation and data analysis have been applied to the study of oncogenomics. With the amount of research conducted on cancer genomes and the accumulation of databases documenting the mutational changes, it has been predicted that the most important cancer-causing mutations, rearrangements, and altered expression levels will be catalogued and well characterized within the next decade. Cancer research may look either on the genomic level at DNA mutations, the epigenetic level at methylation or histone modification changes, the transcription level at altered levels of gene expression, or the protein level at altered levels of protein abundance and function in cancer cells. Oncogenomics focuses on the genomic, epigenomic, and transcript level alterations in cancer.

Market Analysis:

The American Cancer Society reported that among 1.5 million cases half a million die from the disease mostly of breast cancer, lung cancer, bladder cancer, leukemia. The expenditure on cancer care in 2010 was $125 billion and is estimated to reach $156 billion by 2020 in US.US occupies seventh place in breast cancer worldwide.

List of Best International Conferences

1.      9th Cancer Therapy Summit
November 02-04, 2015 Hyderabad, India

2.      Cancer Diagnostics Conference & Expo
June 13-15, 2016 Rome, Italy.

3.      8th Cancer Therapy Conferences
November 03-05, 2015 Valencia, Spain

4.      12th Cancer Therapy Conferences
September 26-28, 2016 London, UK

5.      6th Cancer Therapy Congress
Baltimore, USA

6.      11th Asia-Pacific Oncologists Annual Meeting
July 11-13, 2016 Kuala Lumpur, Malaysia

7.      4th Integrative Biology Conference
July 18-20, 2016 Berlin, Germany

8.      2nd Synthetic Biology Conference
August 15-17, 2016 London, United Kingdom

9.      Pancreatic and Colorectal Cancer Conference
March 29-30, 2016, Atlanta, USA

10.  Prostate Cancer Conference
May 05-07, 2016, Chicago, USA

11.  Genetic Counselling and Genomic Medicine Conference
August 11-12, 2016 Birmingham, UK

12.  Molecular and Cancer Biomarkers Conference and Expo
September 15-17, 2016 Berlin, Germany

13.  Clinical and Molecular Genetics Conference
November 28-30, 2016 Chicago, USA

14.  5th  Cell and Gene Therapy Conference
May 19-21, 2016 San Antonio, USA

15.  2nd Transcriptomics Conference
August 18-20, 2016 Portland, Oregon USA

16.  6th Bioinformatics Conference
March 29-30, 2016 Valencia, Spain

17.  6th Proteomics Conference
March 31-Apr 2, 2016, Atlanta, USA

18.  5th Metabolomics Conference
May 16-18, 2016, Osaka, Japan

19.  Structural Biology Conference
June 23-24, 2016, New Orleans, USA

20.  European Cancer Congress, Vienna, Austria

21.  2015 Northeast Cancer Conference, Troy, NY

22.  NCRI Cancer Conference, Liverpool

23.  Advances in Breast Cancer Research, Bellevue, Washington

24.  International Conference on Molecular Targets and Cancer Therapeutics, Boston, Massachusetts

25.  New Horizons in Cancer Research Conference: Bringing Cancer Discoveries to Patients, Shanghai, P.R. China

26.  Chromatin and Epigenetics in Cancer, Atlanta, Georgia

27.  Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, Orlando, Florida

28.  World Cancer Congress, Paris, France

29.  European Cancer Congress, Vienna, Austria

30.  Breast Cancer Conference, Brussels, Belgium

31.  European Breast Cancer Conference, Amsterdam, The Netherlands

Relevant Societies and Associations:

1.      The Association of Bimolecular Resource Facilities (ABRF), Bethesda, MD, USA

2.      American Society of Gene and Cell Therapy, Milwaukee, Wisconsin, USA

3.      American Society for Microbiology, USA

4.      RNA Society - Maryland, USA

5.      Society for Industrial Microbiology and Biotechnology, Fairfax, Virginia, USA

6.      Federation of American Societies for Experimental Biology (FASEB), Maryland, USA

7.      BioFlorida- Life Science Community

8.      European Society of Human Genetics, Vienna, Austria

9.      European Society for Medical Oncology

10.  European Society of Gynaecological Oncology

11.  EuroPharm Forum

12.  Friends of Cancer Research

13.  American Cancer Society

14.  National Cancer Institute

15.  German Cancer Aid

16.  Cancer Council Australia

17.  Edinburgh Cancer Research Centre

18.  World Cancer Research Fund, UK


1.      Affymetrix - Santa Clara, California USA

2.      Roche NimbleGen Inc. Madison, Wisconsin, United States

3.      SciGene Sunnyvale, California, United States\

4.      Arrayit Corporation

5.      DNAmicroarray California, USA

6.      LC Sciences, Houston, TX, US

7.      SeqWright Genomic Services (a unit of GE health care)

8.      Roche

9.      Novartis

10.  Celgene

11.  Bristol-Myers Squibb 

12.  Lilly 

13.  Takeda 

14.  Merck & Co. 

15.  AstraZeneca  

16.  Pfizer 

17.  Pharmacyclics


This page will be updated regularly.

This page was last updated on May 29, 2023

Conference Series Destinations